[
  {
    "ts": null,
    "headline": "Saudi Arabia Liquid Dietary Supplements Market Analysis & Opportunity Report 2025 Featuring Nestle, Abbott, Bayer, Herbalife Nutrition, and NOW Foods",
    "summary": "The Saudi Arabia liquid dietary supplements market is growing due to rising health awareness, preference for preventive care, and demand for convenient liquid formulations. Key opportunities include prenatal and bone & joint supplements, expanded online sales, and tailored nutrition services, despite challenges like high competition and market fragmentation. Saudi Arabian Liquid Dietary Supplements Market Saudi Arabian Liquid Dietary Supplements Market Dublin, Oct. 07, 2025 (GLOBE NEWSWIRE) -- T",
    "url": "https://finnhub.io/api/news?id=2370c786c38c84196dd17b229f2b19319aa3edc3f35766725d4275abb6d193a1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759843680,
      "headline": "Saudi Arabia Liquid Dietary Supplements Market Analysis & Opportunity Report 2025 Featuring Nestle, Abbott, Bayer, Herbalife Nutrition, and NOW Foods",
      "id": 136999009,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The Saudi Arabia liquid dietary supplements market is growing due to rising health awareness, preference for preventive care, and demand for convenient liquid formulations. Key opportunities include prenatal and bone & joint supplements, expanded online sales, and tailored nutrition services, despite challenges like high competition and market fragmentation. Saudi Arabian Liquid Dietary Supplements Market Saudi Arabian Liquid Dietary Supplements Market Dublin, Oct. 07, 2025 (GLOBE NEWSWIRE) -- T",
      "url": "https://finnhub.io/api/news?id=2370c786c38c84196dd17b229f2b19319aa3edc3f35766725d4275abb6d193a1"
    }
  },
  {
    "ts": null,
    "headline": "QuantiPath Appoints Jeff Nauseda as Director of Market Development -- Bolstering Beef & Pet Food Reach Ahead of GenoPATHX Launch",
    "summary": "QuantiPath (quantipath.bio), the biotechnology company advancing genomic pathogen diagnostics for food safety, today announced the appointment of Jeff Nauseda as Director of Market Development, with principal responsibility for scaling QuantiPath's presence in the beef and pet food sectors. This strategic hire strengthens a leadership team that already offers deep coverage in poultry and swine.",
    "url": "https://finnhub.io/api/news?id=385e77cac0bf8ed8e41ba45db839410dd4da67fa77e2c44f297d5504cd0fa49a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759842180,
      "headline": "QuantiPath Appoints Jeff Nauseda as Director of Market Development -- Bolstering Beef & Pet Food Reach Ahead of GenoPATHX Launch",
      "id": 136999011,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "QuantiPath (quantipath.bio), the biotechnology company advancing genomic pathogen diagnostics for food safety, today announced the appointment of Jeff Nauseda as Director of Market Development, with principal responsibility for scaling QuantiPath's presence in the beef and pet food sectors. This strategic hire strengthens a leadership team that already offers deep coverage in poultry and swine.",
      "url": "https://finnhub.io/api/news?id=385e77cac0bf8ed8e41ba45db839410dd4da67fa77e2c44f297d5504cd0fa49a"
    }
  },
  {
    "ts": null,
    "headline": "Assessing Abbott (ABT) Valuation Following First Health Canada Approval for Innovative Esprit BTK Dissolvable Stent",
    "summary": "Abbott Laboratories (ABT) just received Health Canada approval for its Esprit BTK Everolimus Eluting Resorbable Scaffold System, a dissolvable stent designed to treat chronic limb threatening ischemia below the knee. This regulatory milestone is boosting attention on Abbott’s device pipeline and its long-term growth prospects. See our latest analysis for Abbott Laboratories. Abbott’s approval win arrives just as momentum in its medical device business is starting to build again. With shares...",
    "url": "https://finnhub.io/api/news?id=5dfcf87739a397cf6a7daa91f89669245d5267276915499b400ced5b2c797e62",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759842125,
      "headline": "Assessing Abbott (ABT) Valuation Following First Health Canada Approval for Innovative Esprit BTK Dissolvable Stent",
      "id": 136999012,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories (ABT) just received Health Canada approval for its Esprit BTK Everolimus Eluting Resorbable Scaffold System, a dissolvable stent designed to treat chronic limb threatening ischemia below the knee. This regulatory milestone is boosting attention on Abbott’s device pipeline and its long-term growth prospects. See our latest analysis for Abbott Laboratories. Abbott’s approval win arrives just as momentum in its medical device business is starting to build again. With shares...",
      "url": "https://finnhub.io/api/news?id=5dfcf87739a397cf6a7daa91f89669245d5267276915499b400ced5b2c797e62"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories' (NYSE:ABT) Returns On Capital Are Heading Higher",
    "summary": "If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...",
    "url": "https://finnhub.io/api/news?id=82fc92771f08c4949a90a8639e83e7bdbc36467dc67ed8bcecf53014f905e442",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759834856,
      "headline": "Abbott Laboratories' (NYSE:ABT) Returns On Capital Are Heading Higher",
      "id": 136999013,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...",
      "url": "https://finnhub.io/api/news?id=82fc92771f08c4949a90a8639e83e7bdbc36467dc67ed8bcecf53014f905e442"
    }
  },
  {
    "ts": null,
    "headline": "US Human Papilloma Virus (HPV) Testing Market Forecast Report 2025-2033: California, Texas, New York, and Florida Lead Through Innovation, Accessibility, and Preventive Healthcare Initiatives",
    "summary": "The U.S. Human Papilloma Virus (HPV) testing market is poised for significant growth, projected to reach $1.01 billion by 2033 from $457.52 million in 2024 with a 9.24% CAGR. Key drivers include rising cervical cancer awareness, expanded screening programs, and technological advancements. Regulatory approvals, like Abbott's Alinity m HR HPV assay and Roche's Cobas test, enhance diagnostic options. Increasing self-sampling access and public-private partnerships support underserved populations. Ch",
    "url": "https://finnhub.io/api/news?id=c2f327f1562b979f9df59fe0d73a5428badfa8c8429ffedf7d217fef252bccb3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759834560,
      "headline": "US Human Papilloma Virus (HPV) Testing Market Forecast Report 2025-2033: California, Texas, New York, and Florida Lead Through Innovation, Accessibility, and Preventive Healthcare Initiatives",
      "id": 136999015,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The U.S. Human Papilloma Virus (HPV) testing market is poised for significant growth, projected to reach $1.01 billion by 2033 from $457.52 million in 2024 with a 9.24% CAGR. Key drivers include rising cervical cancer awareness, expanded screening programs, and technological advancements. Regulatory approvals, like Abbott's Alinity m HR HPV assay and Roche's Cobas test, enhance diagnostic options. Increasing self-sampling access and public-private partnerships support underserved populations. Ch",
      "url": "https://finnhub.io/api/news?id=c2f327f1562b979f9df59fe0d73a5428badfa8c8429ffedf7d217fef252bccb3"
    }
  },
  {
    "ts": null,
    "headline": "3 Dividend Stocks to Double Up On Right Now",
    "summary": "The time is right for buying more of these great dividend stocks.",
    "url": "https://finnhub.io/api/news?id=bc892e5ed3a8656c2ad82c0c11836ea3a2df1e8034124cc294bcf8e6ddf67e9b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759826640,
      "headline": "3 Dividend Stocks to Double Up On Right Now",
      "id": 136998887,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The time is right for buying more of these great dividend stocks.",
      "url": "https://finnhub.io/api/news?id=bc892e5ed3a8656c2ad82c0c11836ea3a2df1e8034124cc294bcf8e6ddf67e9b"
    }
  }
]